Dear Colleagues:
Below is an excerpt from a recent NIH policy notice. Please review the notice and forward it to faculty, researchers, and staff, as appropriate. Questions regarding the notices should be directed to your Federal Contract and Grant Officer.
Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period
“By way of this Notice, the National Institutes of Health (NIH) hereby grants the automatic extension of Early-Stage Investigator (ESI) eligibility. This extension addresses delays impacting grant application submissions, peer review, or award processing timelines between January 1, 2025, and May 31, 2025, and seeks to mitigate their effects on the biomedical research community…
· Investigators whose last submission date for a new/resubmission application, based on ESI eligibility, was October/November 2024 will be granted a three-receipt cycle extension (roughly twelve additional months). The last submission as an ESI will be October 2025
· Individuals whose last submission date for a new/resubmission application, based on ESI eligibility, was February/March 2025 will be granted a two-receipt cycle extension (roughly eight additional months). The last submission as an ESI will be October 2025
· Individuals whose last submission date for a new/resubmission application, based on ESI eligibility, will be June/July 2025 will be granted a one-receipt cycle extension (roughly four additional months). The last submission as an ESI will be October 2025.”
Regards,
Jeff Warner
Senior Director, Sponsored Projects
Office of Research
University of California Irvine
949-824-7654
From: Table of Contents for the NIH Guide for Grants & Contracts <NIHTOC-L@LIST.NIH.GOV> On Behalf Of Guide TOC
Sent: Friday, May 23, 2025 11:18 AM
To: NIHTOC-L@LIST.NIH.GOV
Subject: NIH Funding Opportunities and Notices for 05-23-2025 (The NIH Guide TOC)
NIH Guide for Grants and Contracts (Web Version)
Weekly NIH Funding Opportunities and Notices for May 23, 2025
Policy Notices
- Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period
(NOT-OD-25-114)
Office of the Director, NIH
General Notices
- Notice to Rescind NOT-AI-21-037 “Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs”
(NOT-AI-25-036)
National Institute of Allergy and Infectious Diseases
- Notice Announcing Webinar and Frequently Asked Questions (FAQs) for PAR-25-311 Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities
(NOT-HD-25-002)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice to Rescind NOT-OD-25-023 “Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees”
(NOT-OD-25-119)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Change to Key Dates Listed in PAR-22-130, “NIA Program Project Applications (P01 Clinical Trial Optional)”
(NOT-AG-25-018)
National Institute on Aging
- Notice of Early Expiration of PAR-23-300, “Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)”
(NOT-AI-25-037)
National Institute of Allergy and Infectious Diseases
- Notice of Early Expiration of NOT-DE-23-004, Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronovirus Disease 2019 (COVID-19)
(NOT-DE-25-048)
National Institute of Dental and Craniofacial Research
- Notice of Change: Expiration of PAR-25-312: Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)
(NOT-DK-26-328)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Extension to PAR-25-028 “Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)”
(NOT-HL-25-011)
National Heart, Lung, and Blood Institute
- Notice of Extension to PAR-25-029 “Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)”
(NOT-HL-25-012)
National Heart, Lung, and Blood Institute
- Notice of Extension to PAR-22-193 “Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)”
(NOT-HL-25-014)
National Heart, Lung, and Blood Institute
- Notice to Extend the Expiration Date of PAR-25-238 NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
(NOT-LM-25-004)
National Library of Medicine
- Notice of Change to Receipt Dates for RFA-OD-25-003 “Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)”
(NOT-OD-25-103)
Office of Behavioral and Social Sciences Research
- Notice of Extension of the Expiration Date for RFA-OD-22-013 “Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)”
(NOT-OD-25-109)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Funding Opportunities
- (none)
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Unsubscribe from the NIH Guide Weekly TOC LISTSERV.